Top 6 Vendors in the Infertility Services Market in the US from 2017-2021: Technavio

Technavio has published a new report on the infertility services market in the US from 2017-2021. (Photo: Business Wire)

???pagination.previous??? ???pagination.next???

LONDON--()--Technavio has announced the top six leading vendors in their recent infertility services market in the US report until 2021. This research report also lists 21 other prominent vendors that are expected to impact the market during the forecast period.

The research study by Technavio on the infertility services market in the US for 2017-2021 provides a detailed industry analysis based on underlying cause (male infertility and female infertility) and services (assisted reproductive technology (ART) and infertility drugs).

The infertility services market in the US is projected to grow to USD 4.82 billion by 2021, at a CAGR of close to 5% over the forecast period. Assisted reproductive technology will be the leading service in the market, responsible for generating over 72% of the overall revenue,” says Amber Chourasia, a lead analyst at Technavio for health and wellness research.

Competitive vendor landscape

The fertility services market in the US is highly fragmented and with vendors undergoing M&As to extend their product portfolio and expand their geographical presence. Vendors are also investing extensively in R&D to manufacture innovative products to provide value-added service offerings and gain a competitive edge in the market. The market is attracting many new entrants such as Merck and Ferring Pharmaceuticals who offer hormone treatment medication and CooperSurgical who offer fertility media and equipment. Also, collaborations among pharmaceutical companies are leading to the development of novel fertility drugs using technologies of all the collaborating corporations.

Request a sample report: http://www.technavio.com/request-a-sample?report=56871

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Top six vendors in the infertility services market in the US

CARE Fertility

CARE Fertility provides a wide range of products for fertility treatment, genetic diagnosis, screening techniques, and associated fertility preservation procedures. It also provides the genetics program that offers pre-implantation genetic screening and genetic screening and donation programs.

CooperSurgical

CooperSurgical has an extensive product line, including disposable products and sophisticated instruments and equipment. It manufactures and markets medical devices and procedural solutions, and focuses on delivering quality healthcare products for women. The company offers ART products to points of healthcare delivery, such as hospitals and clinics.

Ferring Pharmaceuticals

Ferring Pharmaceuticals engages in the R&D and marketing of a wide range of drugs in the areas of osteoarthritis, endocrinology, gastroenterology, urology, obstetrics, and infertility. It has nine R&D centers worldwide. The company is a provider of ART-based fertility treatments.

Monash IVF

Monash IVF offers acupuncture, naturopathy, herbal medicine and supplements, and counseling services. It also offers conception timing, ovulation induction, assisted insemination, sperm retrieval, intracytoplasmic sperm injection, vitrification, blastocysts, egg donation, sperm donations, embryo donations, in-vitro fertilization, embryo genetic testing, and embryo freezing.

Merck

Merck offers healthcare solutions, such as preventative agents and therapeutics, neuromuscular blocking agents, and animal health products. The pharmaceuticals segment has a complete portfolio of recombinant gonadotropins, including Gonal-F, the most frequently prescribed gonadotropin worldwide.

Vitrolife

Vitrolife designs, develops, and markets instruments and systems for the preparation, cultivation, and preservation of human tissues, cells, and organs. The company focuses primarily on fertility treatments, cell therapy and tissue engineering, and organ transplantation systems.

Browse Related Reports:

Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like agricultural equipment, category spend intelligence, and furniture and home furnishing. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.

About Technavio

Technavio is leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, resellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com

Release Summary

Technavio has announced the top six leading vendors in their recent infertility services market in the US report until 2021.

$Cashtags

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com